Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Kate Attfield awarded project funding by Connect Immune Research and The Lorna and Yuti Chernajovsky Biomedical Research Foundation.

Headshot of Kate Attfield © Kate Attfield

Dr Kate Attfield, a Junior Principal Investigator and member of the Oxford Centre for Neuroinflammation at the MRC Human Immunology Unit, has been awarded funding for the project ‘Applying functional genomics to identify causal cell states across autoimmune disease’.

"This is a great opportunity to explore new ways to identify causal cells in autoimmune disease, using genetics as the foundation on which to create new treatment options that provide safer and greater efficacy for patients" says Dr Attfield. "I look forward to developing this study with a supportive team of collaborators within the MRC HIU and NDCN."

One of ten new pilot projects announced to identify underlying causes of autoimmune diseases, the project aims to explore how individual immune cells can be driven to cause auto-immune diseases such as multiple sclerosis and bowel disease, and how new treatments may be developed to redirect this process.

“The Chernajovsky Foundation is delighted to be funding these innovative translational research projects with our Connect Immune Research partners, which we hope will improve the lives of people living with autoimmune conditions” says Professor Yuti Chernajovsky, co-founder and trustee of the Lorna and Yuti Chernajovsky Biomedical Research Foundation. “We look forward to seeing the projects develop as part of a new collaborative approach to research on autoimmunity.”

Read the full press release on the British Society for Immunology website.

Similar stories

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.

Insights into the molecular pathways of progressive multiple sclerosis

Text by Ian Fyfe for 'Nature Reviews Neurology'

Discovery of gene involved in chronic pain creates new treatment target

Our researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord. This is helping them to understand an important mechanism underlying chronic pain in humans, and provides a new treatment target.

Lymph nodes reveal more about mechanisms of autoimmunity

Two recent papers show that studying lymph nodes reveals details of the mechanisms of autoimmunity.

Multiple heart-related conditions linked to triple dementia risk, regardless of genetics

Having multiple conditions that affect the heart is linked to a greater risk of dementia than having high genetic risk, according to a large-scale new study.